A WORLDWIDE ALLERGY COMPANY

Stallergenes Greer in brief

Headquartered in London (UK), Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies.

Our commitment

Enable people with allergies to live
normal lives.

Focus on AIT

Rapidly growing numbers of people are affected by the allergens that are found in everyday living. Allergies to pollen, house dust mites, animal hair, food and more put boundaries on the way people live.

Press release

November 20, 2018

Stallergenes Greer Announces That the Phase III Trial for Its Sublingual Allergy Immunotherapy Tablet STAGR320 to Treat House Dust Mite-Induced Allergic Rhinitis Achieved Its Primary Endpoint

All press releases
Follow us on Twitter